Monitoring of the lung disorder caused by the treatment of everolimus for the TKI refractory advanced RCC.

Monitoring of the lung disorder caused by the treatment of everolimus for the TKI refractory advanced RCC. - Monitoring of the lung disorder caused by the treatment of everolimus for the TKI refractory advanced RCC.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000004139

Enrollment

Registered

2010-10-10

Start date

2010-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal cell carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: TKI refractory advanced RCC patients.

Exclusion criteria

Exclusion criteria: everolimus hypersensitivity pregnant female

Design outcomes

Primary

Measure	Time frame
Correlation of the serum biomarkers and the findings of CT scan with early detection of pulmonary injury caused by everolimus.	—

Countries

Japan

Outcome results